We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-6.01%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$29.4B
AUM Growth
-$1.98B
Cap. Flow
+$417M
Cap. Flow %
1.42%
Top 10 Hldgs %
13.7%
Holding
3,077
New
38
Increased
2,518
Reduced
390
Closed
63

Sector Composition

Rank Sector Weight
1 Financials 15.39%
2 Healthcare 14.23%
3 Technology 14.23%
4 Industrials 10.63%
5 Consumer Discretionary 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
2426
Arrowhead Research
ARWR
$12.3B
$366K ﹤0.01%
63,615
+3,035
+5% +$19.1K
ATEX icon
2427
Anterix
ATEX
$1.94B
$366K ﹤0.01%
12,255
+575
+5% +$18.8K
WPP
2428
DELISTED
WAUSAU PAPER CORP.
WPP
$366K ﹤0.01%
57,184
+412
+0.7% +$3.34K
NNA
2429
DELISTED
Navios Maritime Acquisition Corporation
NNA
$365K ﹤0.01%
6,911
+405
+6% +$23.1K
SYT
2430
DELISTED
Syngenta Ag
SYT
$365K ﹤0.01%
5,717
+200
+4% +$15.2K
OSIR
2431
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$364K ﹤0.01%
19,689
+635
+3% +$12.3K
ARAY icon
2432
Accuray
ARAY
$32.8M
$363K ﹤0.01%
72,677
+1,706
+2% +$11K
PCBK
2433
DELISTED
Pacific Continental Corp
PCBK
$363K ﹤0.01%
27,257
+1,435
+6% +$19K
SGMO
2434
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$361K ﹤0.01%
64,008
-3,462
-5% -$28.5K
VIRT icon
2435
Virtu Financial
VIRT
$5.16B
$361K ﹤0.01%
15,731
+671
+4% +$15.4K
SGNT
2436
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$361K ﹤0.01%
23,545
+936
+4% +$20.2K
ANIP icon
2437
ANI Pharmaceuticals
ANIP
$1.8B
$360K ﹤0.01%
9,116
+196
+2% +$11.2K
TROX icon
2438
Tronox
TROX
$933M
$359K ﹤0.01%
82,104
+4,704
+6% +$43.8K
CCNE icon
2439
CNB Financial Corp
CCNE
$1.05B
$357K ﹤0.01%
19,666
+1,046
+6% +$18.5K
RMTI icon
2440
Rockwell Medical
RMTI
$28.7M
$355K ﹤0.01%
419
+17
+4% +$24.6K
FGL
2441
DELISTED
Fidelity & Guaranty Life
FGL
$352K ﹤0.01%
14,340
+840
+6% +$20.8K
FF icon
2442
Future Fuel
FF
$217M
$351K ﹤0.01%
35,535
+1,683
+5% +$18.2K
KERX
2443
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$351K ﹤0.01%
99,631
-65
-0.1% -$435
ENB icon
2444
Enbridge
ENB
$113B
$350K ﹤0.01%
9,420
HBNC icon
2445
Horizon Bancorp
HBNC
$1.06B
$350K ﹤0.01%
33,113
+5,728
+21% +$62.6K
RLD
2446
DELISTED
REALD INC COM STK
RLD
$350K ﹤0.01%
36,459
+1,314
+4% +$14.2K
CASH icon
2447
Pathward Financial
CASH
$1.88B
$349K ﹤0.01%
25,074
+1,644
+7% +$25.1K
NGS icon
2448
Natural Gas Services Group
NGS
$472M
$349K ﹤0.01%
18,063
-25
-0.1% -$513
BCE icon
2449
BCE
BCE
$20.6B
$348K ﹤0.01%
8,500
TBBK icon
2450
The Bancorp
TBBK
$2.99B
$348K ﹤0.01%
45,612
+2,376
+5% +$19.8K

Similar funds

RhumbLine Advisers's Q3 2015 Portfolio in Review

As of Q3 2015, RhumbLine Advisers held 3,077 positions worth $29.4B, down 6.3% from $31.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 3.3%. RhumbLine Advisers opened 38 new positions and exited 63, leaving the 3,077-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • RhumbLine Advisers's largest Q3 2015 buy was Alphabet (Google) Class A: 7,673,640 shares worth $245M.
  • RhumbLine Advisers added most to AT&T in Q3 2015, an estimated $48.4M increase.
  • RhumbLine Advisers's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $231M.
  • RhumbLine Advisers fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $29.4B portfolio in Q3 2015.
  • RhumbLine Advisers opened 38 new positions and closed 63 in Q3 2015.
  • RhumbLine Advisers's portfolio value fell 6.3% quarter-over-quarter to $29.4B.

Based on RhumbLine Advisers's 13F filing for Q3 2015, filed 4 Nov 2015.